Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Form 8.3 - Pfizer, Inc.

19 Nov 2015 11:55

RNS Number : 2300G
Capital Group Companies Inc
19 November 2015
Β 

FORMΒ 8.3

Β 

IRISHΒ TAKEOVERΒ PANEL

Β 

DISCLOSUREΒ UNDERΒ RULEΒ 8.3Β OFΒ THEΒ IRISHΒ TAKEOVERΒ PANEL ACT,Β 1997,Β TAKEOVERΒ RULES,Β 2013

Β 

DEALINGSΒ BYΒ PERSONSΒ WITHΒ INTERESTSΒ INΒ RELEVANTΒ SECURITIESΒ REPRESENTINGΒ 1%Β ORΒ MORE

Β 

Β 

1. KEYΒ INFORMATION

Β 

Name of person dealing (Note 1)

The Capital Group Companies, Inc.

Company dealt in

Pfizer Inc.

Class of relevant security to which the dealings being disclosed relate (Note 2)

US$0.05 Common Stock

(ISIN: US7170811035)

Date of dealing

18 November 2015

Β 

2. INTERESTSΒ ANDΒ SHORTΒ POSITIONS

Β 

(a) InterestsΒ andΒ shortΒ positionsΒ (followingΒ dealing)Β inΒ theΒ classΒ ofΒ relevantΒ securityΒ dealtΒ inΒ (NoteΒ 3)

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

136,388,323 (2.21%)

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

136,388,3231 (2.21%)

Β 

(b) InterestsΒ andΒ shortΒ positionsΒ inΒ relevantΒ securitiesΒ ofΒ theΒ company,Β otherΒ thanΒ theΒ classΒ dealtΒ inΒ (NoteΒ 3)

Β 

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

Β 

Β 

1. DEALINGSΒ (NoteΒ 4)

Β 

(a) PurchasesΒ andΒ sales

Β 

Β 

Purchase/sale

Β 

Number of relevant securities

Β 

Price per unit (Note 5)

Sale

275,070

33.0305 - USD

Sale

134,975

33.0854 - USD

Purchase

6,400

33.2613 - USD

Β 

Β 

(b) DerivativesΒ transactionsΒ (otherΒ thanΒ optionsΒ transactions)

Β 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

Β 

Β 

(c) OptionsΒ transactionsΒ inΒ respectΒ ofΒ existingΒ relevantΒ securities

Β 

Β 

(i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Β 

Β 

(ii) Exercising

Β 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

Β 

Β 

(d) OtherΒ dealingsΒ (includingΒ transactionsΒ inΒ respectΒ ofΒ newΒ securities)Β (NoteΒ 4)

Β 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Β 

OTHERΒ INFORMATION

Β 

Agreements,Β arrangementsΒ orΒ understandingsΒ relatingΒ toΒ optionsΒ orΒ derivatives

Β 

Β 

Β 

Β 

FullΒ detailsΒ ofΒ anyΒ agreement,Β arrangementΒ orΒ understandingΒ betweenΒ theΒ personΒ disclosing andΒ anyΒ otherΒ personΒ relatingΒ toΒ theΒ votingΒ rightsΒ ofΒ anyΒ relevantΒ securitiesΒ underΒ anyΒ option referredΒ toΒ onΒ thisΒ formΒ orΒ relatingΒ toΒ theΒ votingΒ rightsΒ orΒ futureΒ acquisitionΒ orΒ disposalΒ ofΒ anyrelevantΒ securitiesΒ toΒ whichΒ anyΒ derivativeΒ referredΒ toΒ onΒ thisΒ formΒ isΒ referenced.Β IfΒ none,Β thisshouldΒ beΒ stated.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

IsΒ aΒ SupplementalΒ FormΒ 8Β attached?Β (NoteΒ 9) NO

Β 

Date of disclosure

18 November 2015

Contact name

Gina Martinez

Telephone number

+213.615.0469

If a connected EFM, name of offeree/offeror with which connected

n/a

If a connected EFM, state nature of connection (Note 10)

n/a

Β 

1200 shares due to an off market transfer out.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ISEBLBMTMBMBMLA
Date   Source Headline
22nd May 201410:47 amRNSForm 8.5 (EPT/RI) Pfizer Inc
22nd May 201410:47 amRNSForm 8.5 (EPT/RI) Pfizer Inc
22nd May 20149:21 amRNSRule 2.10 Announcement
22nd May 20149:14 amBUSForm 8.3 - Pfizer Inc
22nd May 20147:00 amPRNForm 8.3 - Pfizer Inc.
21st May 20145:35 pmRNSForm 8 (DD) - [Pfizer Inc] - Amendment
21st May 20145:28 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
21st May 20145:23 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
21st May 20145:22 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
21st May 20145:13 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
21st May 20145:09 pmRNSForm 8 (DD) - Pfizer Inc
21st May 20145:08 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
21st May 20143:44 pmRNSForm 8.3 - Pfizer Inc
21st May 20143:32 pmRNSForm 8.3 - Astrazeneca PLC
21st May 20143:31 pmRNSForm 8.3 - [Pfizer Inc]
21st May 20143:17 pmRNSForm 8.3 -Pfizer Inc
21st May 20143:15 pmRNSForm 8.3 - Pfizer Inc
21st May 20142:57 pmRNSForm 8.3 - [PFIZER INC]
21st May 20142:56 pmRNSForm 8.3 - Pfizer Inc
21st May 20142:46 pmRNSForm 8 (DD) - Pfizer Inc.
21st May 20142:46 pmBUSForm 8.3 - Pfizer Inc.
21st May 20142:42 pmRNSForm 8.3 - Pfizer Inc
21st May 20142:25 pmBUSForm 8.3 - Pfizer Inc
21st May 20141:23 pmRNSForm 8.3 - Pfizer Inc
21st May 20141:22 pmRNSForm 8.3 - AstraZeneca Plc
21st May 201412:35 pmBUSForm 8.3 - Pfizer Inc
21st May 201412:07 pmRNSForm 8.5 (EPT/NON-RI) Amendment
21st May 201411:55 amRNSForm 8.3 - Pfizer Inc.
21st May 201411:49 amRNSReplacement - Form 8 (OPD) (Pfizer)
21st May 201411:49 amRNSReplacement - Form 8 (OPD) (Pfizer)
21st May 201411:40 amRNSForm 8.3 - Pfizer Inc
21st May 201411:37 amRNSForm 8 (DD) - [Pfizer Inc]
21st May 201411:33 amRNSForm 8.5 (EPT/RI)
21st May 201411:29 amRNSRule 2.10 Announcement
21st May 201411:28 amRNSForm 8.5 (EPT/NON-RI)
21st May 201411:22 amRNSForm 8.5 (EPT/RI)
21st May 201411:09 amRNSForm 8.5 (EPT/RI) Pfizer Inc
21st May 201411:08 amRNSForm 8.5 (EPT/RI) Pfizer Inc
21st May 201411:07 amRNSForm 8.5 (EPT/RI) Pfizer Inc
21st May 201411:04 amRNSForm 8.5 (EPT/RI) Pfizer Inc
21st May 201410:32 amRNSRule 2.10 Announcement
21st May 201410:27 amRNSForm 8.3 - Pfizer Inc
21st May 20147:00 amPRNForm 8.3 - Pfizer Inc.
20th May 20146:17 pmRNSCLARIFICATION REGARDING PFIZER STATEMENT
20th May 20145:13 pmRNSForm 8 (DD) - [Pfizer Inc] - Amendment
20th May 20144:54 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
20th May 20144:31 pmBUSForm 8.3 - Pfizer Inc
20th May 20143:47 pmRNSForm 8.3 - [PFIZER INC]
20th May 20143:36 pmRNSForm 8.3 - Pfizer Inc
20th May 20143:23 pmRNSForm 8.3 - Pfizer Inc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.